Real-world lecanemab data show ARIA risks and limited cognitive evidence
A meta-analysis of 37 real-world lecanemab studies found ARIA in 15.1% of cases, with higher rates among APOE ε4 homozygotes ...
A meta-analysis of 37 real-world lecanemab studies found ARIA in 15.1% of cases, with higher rates among APOE ε4 homozygotes ...
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
A Sutter Health virtual review board allowed general neurologists to safely prescribe and monitor amyloid-targeting Alzheimer's therapies in community settings, ...
University of Bath researchers have won £1.9 million from ARIA to develop STRAT-NAV, a forecasting and routing system that lets ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine